Company intelligence / Profile preview

Hudson Innovations

Ownership: Private
Development stage: Other

Overview

No specific clinical results available for Hudson Innovations itself. Dr. Bruce Forrest brings extensive global pharmaceutical development experience, especially in vaccines and biopharmaceuticals across major markets including Asia/Japan, with a track record of leading successful late-stage clinical programs at Wyeth Pharmaceuticals and overseeing product approvals for multiple therapeutics/vaccines in Japan and globally[9].

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Consulting

Beyond the preview

Go deeper on Hudson Innovations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hudson Innovations.

Explore the full profile